News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Zongertinib breakthrough: Elizabeth McKenna highlights new study on HER2-driven cancers
Elizabeth McKenna/X
May 1, 2025, 17:54

Zongertinib breakthrough: Elizabeth McKenna highlights new study on HER2-driven cancers

Elizabeth McKenna, Executive Editor of Cancer Discovery, shared a post on X about a recent article by Birgit Wilding et al. published in Cancer Discovery, adding:

“ICYMI in Cancer Discovery – AACR ahead of today’s big clinical plenary at AACR25 – the preclinical characterization and early clinical proof-of-concept of zongertinib, an irreversible HER2 TKI that spares EGFR signaling and has activity in HER2-driven cancers.”

Elizabeth McKenna

Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers

Authors: Birgit Wilding et al.

Elizabeth McKenna

Learn more about Zongertinib in cancer treatment on OncoDaily.

AACR25 Anke Baum Anna C. Obenauf Annemarie Bruining Birgit Wilding cancer Cancer Discovery Daniel Gerlach Dirk Scharn Fiona Spreitzer Flavio Solca Frans L. Opdam Gintautas Vainorius Irene C. Waizenegger Johannes Popow John V. Heymach Krzysztof Chylinski Lydia Woelflingseder Mark A. Pearson Martin Augsten Masachika Ikegami Neil Gibson Noboru Yamamoto Norbert Kraut OncoDaily Oncology Ralph A. Neumüller Shinji Kohsaka Shunsuke Kondo Sylvia Tilandyová Yukina Shirai Zongertinib
Special Coverage
Insight
May 21, 2025, 18:49
Joe Y. Chang on upcoming PTCOG 63: IMRT vs IMPT Phase III trials
Blog
May 21, 2025, 18:11
Poland’s Cancer Landscape at Cancer Mission Fair - European Cancer Organisation
Insight
May 21, 2025, 18:05
Goutham Sunny on KRAS G12C inhibition in non-small cell lung cancer
Blog
May 21, 2025, 18:02
Tackling Information Overload in Cancer Research - Train at NCI
Societies
May 21, 2025, 17:54
Patrick Hwu: Kicked off the 2025 Scientific Symposium at Moffitt Cancer Center
Blog
May 21, 2025, 17:54
Applications are Open for the Basic Principles in Oncology Course - European School of Oncology
Career
May 21, 2025, 17:46
Sharon Kapambwe Has Been Appointed as Technical Officer for Cancer Control at WHO Uzbekistan
Opinion
May 21, 2025, 17:41
Bishal Gyawali addressed G7 cancer drug approval claims about Canada with the Lancet Oncology Study
Blog
May 21, 2025, 17:33
From Lung Cancer Risk to Response - UICC
Blog
May 21, 2025, 17:25
Rick Buck Presents on AACR Collaboration at Cancer Marketing and Communications Association Meeting
Insight
May 21, 2025, 17:20
Lung Cancer Europe shared study on short-term prehabilitation in resectable NSCLC patients
Insight
May 21, 2025, 17:12
Tanja Obradovic: Issue of Trial Data Applicability to US Patient Population is Resurfacing Again at FDA